Chicago: Novavax said on Thursday its coronavirus vaccine was 89.3 per cent effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the UK, according to a preliminary analysis. Novavax said the trial, which enrolled 15,000 people aged 18 to 84, is expected to be used to apply for regulatory review in Britain, the European Union and other countries. Some 27 per cent of people in the trial are over age 65. The study took place as the more highly transmissible UK variant was circulating, and the preliminary analysis suggests the vaccine was 85.6 per cent effective again
Hence then, the article about novavax says covid 19 vaccine 89 3 effective in uk trial was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Novavax says COVID-19 vaccine 89.3% effective in UK trial )